Bernard A. Fox

Oregon Health & Science University — United States

Immunology and Microbiology · Life Sciences

62h-index17.7kcitations509works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(283), Cancer Immunotherapy and Biomarkers(241), CAR-T cell therapy research(165), Immune Cell Function and Interaction(79), Monoclonal and Polyclonal Antibodies Research(39)

Publications505 total

Multimodal AI generates virtual population for tumor microenvironment modeling
Cell·2025· 4 citedOpen Access
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells 4593
The Journal of Immunology·2025Open Access
636 Addition of GITR agonist to a dark matter cancer vaccine and anti-PD-1 increases regulatory T cell numbers without appearing to impact therapeutic efficacy
Regular and Young Investigator Award Abstracts·2025Open Access
176 Spatial and seromic profiling of tumor infiltrating B-cell subtypes and autoantibody production in oral cancers
Regular and Young Investigator Award Abstracts·2025Open Access
Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338
The Journal of Immunology·2025Open Access
192 Development of the proteogenomic antibody repertoire assay for anti-tumor antibody discovery
Regular and Young Investigator Award Abstracts·2025Open Access
676 Lymphatic-sparing immunoradiotherapy reprograms migratory dendritic cells to drive tumor rejection via the sentinel lymph node
Regular and Young Investigator Award Abstracts·2025Open Access
163 Unveiling the non-canonical dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC) using mass spectrometry and watchmaker total RNA-Seq
Regular and Young Investigator Award Abstracts·2025Open Access
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
Nature Reviews Clinical Oncology·2025· 8 cited
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
Nature Communications·2025· 10 citedOpen Access
Approaches to overcome the current treatment plateau in immunotherapy
European Journal of Cancer·2025· 2 citedOpen Access
Pathologic response to neoadjuvant sequenced, lymphatic-sparing SBRT plus pembrolizumab in HPV-negative head and neck squamous cell carcinoma.
Journal of Clinical Oncology·2025· 1 cited
Asia’s emergence in cancer immunotherapy: challenges and opportunities
Journal for ImmunoTherapy of Cancer·2025Open Access
Abstract 3764: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Cancer Research·2025
Perspectives on the role of “-Omics” in predicting response to immunotherapy
European Journal of Cancer·2025· 2 citedOpen Access
Abstract B019: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Cancer Immunology Research·2025
Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Clinical Cancer Research·2025
Provides Apparent Predictive Biomarker in a Phase I/II Study of Pembrolizumab With Gemcitabine in Patients with Previously-Treated Advanced Non-Small Cell Lung Cancer (NSCLC)
2024Open Access
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
Nature Communications·2024· 14 citedOpen Access
715 Combining a complex cancer vaccine with anti-PD-1 and DGK inhibitor improves therapeutic efficacy and may augment anti-cancer memory development
Regular and Young Investigator Award Abstracts·2024Open Access
page 1 of 26Next →

Frequent Co-authors

Walter J. Urba(17), Hong‐Ming Hu(15), Paolo A. Ascierto(12), Carlo Bifulco(11), Francesco M. Marincola(10), Jérôme Galon(10), Giuseppe Masucci(9), Carmen Ballesteros‐Merino(9), Franck Pagès(7), Gerardo Botti(7), Shawn M. Jensen(7), Alessandro Lugli(6), Pamela S. Ohashi(6), Gennaro Ciliberto(6), Michele Maio(6), Inti Zlobec(5), Arndt Hartmann(5), Fabio Grizzi(5), Zipei Feng(5), Toshihiko Torigoe(5)